Astria Therapeutics
ATXS
ATXS
35 hedge funds and large institutions have $83.7M invested in Astria Therapeutics in 2015 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
35% less capital invested
Capital invested by funds: $129M → $83.7M (-$45.3M)
Holders
35
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$867K | |
| 2 | +$586K | |
| 3 | +$283K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$263K |
| 5 |
SIM
Spark Investment Management
New York
|
+$263K |
Top Sellers
| 1 | -$2.75M | |
| 2 | -$977K | |
| 3 | -$939K | |
| 4 |
DM
Deerfield Management
New York
|
-$886K |
| 5 |
CC
Clearline Capital
New York
|
-$571K |